DekaBank Deutsche Girozentrale
ORIC icon

DekaBank Deutsche Girozentrale’s Oric Pharmaceuticals ORIC Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,500
Closed -$215K – 1462
2021
Q3 		$215K Hold
10,500
– – ﹤0.01% 1198
2021
Q2 		$181K Hold
10,500
– – ﹤0.01% 1241
2021
Q1 		$249K Hold
10,500
– – ﹤0.01% 1145
2020
Q4 		$408K Buy
+10,500
New +$301K ﹤0.01% 1059

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ORIC Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Oric Pharmaceuticals (ORIC) in Q4 2021, closing a stake of 10,500 shares — an estimated $215K sold.

DekaBank Deutsche Girozentrale first reported a position in ORIC in Q4 2020 and held it in 4 quarters. The position peaked at $408K in Q4 2020. 80 funds tracked by Wall St. Rank hold ORIC as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Oric Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 10,500 Oric Pharmaceuticals shares in Q4 2021, an estimated $215K.
  • DekaBank Deutsche Girozentrale first reported a position in Oric Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Oric Pharmaceuticals position peaked at $408K in Q4 2020.
  • 80 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.